arBtrage CAPITALIZING MARKETS checking… Sign in

Immuneering Corporation

IMRX Health Care Biotechnology: Pharmaceutical Preparations
$4.27
▼ -4.7% Today
as of Jun 7, 07:18 ET
Last 30 days -18.36% Apr 28 → Jun 05
$4.15 $4.58 $5.02 $5.45 $5.89 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$4.46
High
$4.46
Low
$4.20
Volume
$1M
Avg Vol
$2M
Mkt Cap
$327M
P/E (TTM)
Beta
52w High
$10.08
52w Low
$1.66
Div Yield
Shares Out

Overview

52-week range
$1.66
$10
31% of range
Avg surprise (last 2)
+13.8%
Avg reaction (last 2)
+0.6%
100% positive
Latest IV / EM
110%
EM ±15.2% · $5 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.49$-0.42$-0.35$-0.28$-0.21 Actual $-0.43Actual $-0.43Actual $-0.49Actual $-0.47Actual $-0.49Actual $-0.42Est $-0.41Actual $-0.40Actual $-0.38Actual $-0.21Est $-0.30 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-15M$-15M$-15M$-14M$-14M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri May 15, 2026Mar/2026 $-0.21 $-0.30 +30.0% +50.0% +0.4% earnings
Tue Sep 30, 2025Sep 2025 $-0.38 financials
Mon Jun 30, 2025Jun 2025 $-0.40 financials
Mon May 5, 2025Mar/2025 $-0.42 $-0.41 -2.4% +0.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.49 financials
Sun Jun 30, 2024Jun 2024 $-0.47 financials
Sun Mar 31, 2024Mar 2024 $-0.49 financials
Sat Sep 30, 2023Sep 2023 $-0.43 financials
Fri Jun 30, 2023Jun 2023 $-0.43 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-15M$-15M$-15M$-15M$-15M$-15M
Net income$-13M$-15M$-14M$-15M$-15M$-14M
EPS (diluted)$-0.21$-0.38$-0.40$-0.42$-0.49$-0.47

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$47M$129M$228M$26M$36M$36M$45M$60M
Inventory
Total current assets$161M$176M$229M$28M$38M$40M$55M$64M
Total assets$215M$232M$241M$40M$51M$53M$69M$77M
Long-term debt
Total liabilities$8M$14M$13M$11M$9M$11M$11M$11M
Total equity$207M$218M$228M$29M$42M$41M$58M$66M

Implied volatility — last 90 days

104%107%109%112%114% Jun 07 — IV 110% · EM ±15.2%

Sector peers